Evidence map›Paper›PMID 41599131›Full record

ArticlePharmaceutics2025

L19-Conjugated Gold Nanoparticles for the Specific Targeting of EDB-Containing Fibronectin in Neuroblastoma.

Chiara Barisione, Silvia Ortona, Veronica Bensa, Caterina Ivaldo, Eleonora Ciampi, Simonetta Astigiano, Michele Cilli, Luciano Zardi, Mirco Ponzoni, Domenico Palombo and 3 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chiara BarisioneDepartment of Surgical and Integrated Diagnostic Sciences, University of Genoa, 16132 Genoa, Italy.
Silvia OrtonaDepartment of Experimental Medicine, University of Genoa, 16132 Genoa, Italy.
Veronica BensaLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-4927-2731
Caterina IvaldoDepartment of Surgical and Integrated Diagnostic Sciences, University of Genoa, 16132 Genoa, Italy.
Eleonora CiampiLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0009-0003-5044-3184
Simonetta AstigianoAnimal Facility, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Michele CilliAnimal Facility, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Luciano ZardiDepartment of Surgical and Integrated Diagnostic Sciences, University of Genoa, 16132 Genoa, Italy.
Mirco PonzoniLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-6164-4286
Domenico PalomboDepartment of Surgical and Integrated Diagnostic Sciences, University of Genoa, 16132 Genoa, Italy.
Giovanni PratesiDepartment of Surgical and Integrated Diagnostic Sciences, University of Genoa, 16132 Genoa, Italy.
Pier Francesco FerrariIRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.ORCID 0000-0002-7054-3559
Fabio PastorinoLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-8312-808X

Funding

Italian Association for Cancer Research IG 24397OPEN OdV and Fondazione Italiana per la Lotta al Neuroblastoma ONLUS, 2025-2027
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fibronectin extra-domain BL19 gold nanoparticlesneuroblastomaphotoacoustic imaging

Identifiers

PMID41599131
PMCPMC12845290

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.